Vexim SA, a medical device company, provides invasive medical solutions for treatment of vertebral compression fractures. It offers SpineJack, an implant system for use in the anatomical reduction of vertebral compression fractures of traumatic origin; and Masterflow, a system for use in cement delivery in vertebral augmentation. The company also provides 3D-mapping software to evaluate anatomical restoration at both pre-op and post-op stages; biomaterials; and cement mixing systems. Vexim SA is headquartered in Balma, France.
Type
Public
HQ
Balma, FR
Founded
2006
Employees
37 (est)
Vexim was founded in 2006 and is headquartered in Balma, FR

Vexim Locations

Balma, FR

Vexim Metrics

Vexim Summary

Market capitalization

€58.1 M

Closing share price

€9.39
Vexim's latest market capitalization is €58.1 M.

Vexim Market Value History

Vexim Company Life